China Evergrande New Energy Vehicle Group Limited (EVGRF)
OTCMKTS
· Delayed Price · Currency is USD
0.0150
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST
EVGRF Revenue
China Evergrande New Energy Vehicle Group had revenue of 38.38M CNY in the half year ending June 30, 2024, with 59.20% growth. This brings the company's revenue in the last twelve months to 1.22B, up 514.37% year-over-year. In the year 2023, China Evergrande New Energy Vehicle Group had annual revenue of 1.34B with 900.03% growth.
Revenue (ttm)
1.22B CNY
Revenue Growth
+514.37%
P/S Ratio
n/a
Revenue / Employee
912.06K CNY
Employees
1,342
Market Cap
284.84M USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.34B | 1.21B | 900.03% |
Dec 31, 2022 | 134.01M | -2.40B | -94.71% |
Dec 31, 2021 | 2.53B | -12.96B | -83.66% |
Dec 31, 2020 | 15.49B | 9.85B | 174.80% |
Dec 31, 2019 | 5.64B | 2.50B | 79.88% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.66B |
Ryman Healthcare Limited | 458.44M |
Verano Holdings Corp. | 897.57M |
Vireo Growth Inc. | 98.53M |
Medexus Pharmaceuticals Inc. | 104.76M |
China Evergrande New Energy Vehicle Group News
- 2 months ago - Evergrande NEV Stake Sale Talks With Potential Buyer Have Ended - BNN Bloomberg
- 4 months ago - China Evergrande's EV arm warns of bigger first-half loss on impairment provisions - CNBC
- 4 months ago - China Evergrande NEV Warns of $2.85 Billion Loss on Provisions - BNN Bloomberg